Enzon Pharmaceuticals, Inc.
ENZN
Revenue
26.00k
▲26.00k∞%
3 Months ChangeAssets
46.99M
▲165.00k▲0.3523%
3 Months ChangeLiabilities
4.80M
▲40.00k▲0.8402%
3 Months ChangeFree Cash Flow
2.99M
▲3.48M▲702.42%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-01
Form 8-K
ID: 0001104659-24-104951
2024-08-08
Form 10-Q
ID: 0001410578-24-001220
2024-07-02
Form 8-K
ID: 0001104659-24-077371
2024-06-14
Form 8-K
ID: 0001104659-24-071747
2024-05-22
Form 8-K
ID: 0001104659-24-064247
2024-05-10
Form 10-Q
ID: 0001410578-24-000735
2024-01-05
Form 8-K
ID: 0001104659-24-001789
2023-11-09
Form 10-Q
ID: 0001410578-23-002306
2023-08-07
Form 10-Q
ID: 0001410578-23-001577
2023-06-14
Form 8-K
ID: 0001104659-23-071184